{"id":"0fa35765-432d-48ed-ba7e-baf720b12e71","arxiv_id":"2508.14922","paper_version":1,"verdict":"CONDITIONAL","confidence":"LOW","novelty_score":4.0,"correctness_risk":"unknown","formal_verification":"none","parameter_count":1,"one_line_summary":"A random forest that fuses optic nerve head structure from OCT with visual field sensitivity predicts fast versus slow glaucoma progression with AUC 0.87, outperforming single-modality models.","lead":"This paper combines eye scans with visual field tests to predict whether glaucoma patients with narrow drainage angles will lose vision quickly or slowly. A machine learning model using both data types beat models using either one alone, reaching an accuracy score of 0.87.","discovery_kind":"new_application","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Reported 0.87 AUC lacks patient-level cross-validation; with 451 eyes from 299 patients, eye-level splits can leak the same patient into train and test and inflate the combined-model advantage.","rationale":"The reader's verdict is CONDITIONAL, and this stress-test agrees that the study should be conditional on additional validation evidence. However, the reader's weakest_assumption identified AI segmentation of OCT volumes as the key risk. I think the more load-bearing risk is evaluation independence: 451 eyes from 299 patients makes eye-level splits dangerous because of within-patient correlation. This is not an ad hominem concern and not a claim that the authors are dishonest; it is a standard methodological check. If the combined model still beats structural-only in patient-stratified cross-validation with proper confidence intervals, the central claim would be supported. If not, the headline AUC is an artifact of data leakage. The concrete test described would settle the question directly. Because the abstract does not report the necessary validation information, the appropriate verdict remains CONDITIONAL; no reason to move to ACCEPT or REJECT based on available text. I mark agreement as partial because the reader's rationale did mention missing patient-level split details, though the reader's stated weakest assumption was segmentation rather than validation independence.","tokens_in":852,"tokens_out":5350,"duration_ms":56659,"concrete_test":"Re-run the random forest pipeline with patient-stratified nested cross-validation: assign all eyes from a given patient to the same outer fold, tune hyperparameters inside folds, and report out-of-fold AUC with a bootstrap 95% confidence interval for the difference (combined minus structural-only). If the lower bound of the confidence interval includes zero, or if the AUC drops by more than about 0.05 relative to the reported 0.87, the claim of significant improvement is not supported. As a secondary check, repeat the comparison after omitting all functional features; if the combined gain disappears or reverses, the shared VF measurement coupling is implicated.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim is that combining structural and functional features significantly improves PACG progression-risk classification, with AUC 0.87 vs 0.82 structural-only and 0.78 functional-only. The load-bearing assumption is not primarily segmentation quality; it is that the reported AUC differences are evaluated on independent data. The abstract reports 451 eyes from 299 patients, which means many patients contribute two eyes. If the Monte Carlo procedure splits at eye level, the fellow eye of a patient whose other eye is in the training set can appear in the test set. Eyes within a patient are strongly correlated through genetics, anatomy, and shared disease environment, so a model can memorize patient-level signatures and appear to classify better than it would for unseen patients. The abstract gives no patient-stratified folds, no held-out cohort, and no confidence intervals for AUC differences. Monte Carlo iterations alone do not establish generalizability. Additionally, the progression label is derived from VFI slopes from the same VF series that supply the functional features; although baseline sensitivity is not the slope, shared measurement noise can create a subtle coupling. Therefore the 0.87 combined AUC and the claimed incremental benefit over structural-only data are not yet established as real. The segmentation concern raised by the reader is real but secondary: if the evaluation is not independent, even perfect segmentation would not make the headline claim sound.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper proposes a machine-learning approach to classify primary angle closure glaucoma (PACG) eyes as slow or fast progressors by combining optic nerve head (ONH) structural features extracted from AI-segmented OCT volumes with sector-based visual field (VF) functional features. Using 451 eyes from 299 patients, the Random Forest model achieved an AUC of 0.87 for the combined model, compared with 0.82 for structural-only and 0.78 for functional-only models. SHAP analysis identified inferior ONH parameters (e.g., inferior MRW, inferior-temporal RNFL thickness) as the most predictive features. The paper concludes that combining structural and functional data significantly improves progression-risk classification.","tokens_in":1250,"tokens_out":3363,"duration_ms":34459,"significance":"If the reported performance is validated on truly independent data, the work is clinically meaningful: early identification of fast progressors in PACG could guide treatment intensity and monitoring frequency. The integration of structural OCT and functional VF modalities is a sensible and potentially translatable idea, and the use of Monte Carlo iterations for internal validation is a positive aspect. However, the significance hinges critically on the evaluation methodology, particularly on whether the cross-validation respects patient-level independence and whether the reported AUC differences are statistically and practically robust. The current abstract does not provide enough evidence to assess generalizability, so the practical significance is contingent on additional validation.","major_comments":[{"comment":"The abstract reports 451 eyes from 299 patients but does not state whether the Monte Carlo cross-validation splits at the eye level or patient level. Because many patients contribute two eyes, eye-level splits allow correlated fellow eyes to appear in both training and test sets, which can artificially inflate AUC by exploiting patient-specific signatures. Please provide patient-stratified cross-validation (or a held-out cohort) and report AUC with confidence intervals. This is load-bearing for the central claim that the combined model outperforms single-modality models.","section":"Methods/Results (Abstract)"},{"comment":"The fast-progression label is defined by a VFI slope over follow-up, and the functional features are baseline VF sensitivities measured within six months of OCT. Although baseline sensitivity is not the slope, both derive from the same VF tests, so shared measurement noise and disease severity can create coupling between features and label. The abstract states 'baseline VF within six months of OCT' but does not clarify whether any follow-up VF data enter the feature set; if they do, leakage would occur. Please confirm that only baseline VF data were used, and quantify the degree of residual coupling if possible.","section":"Methods (label/feature coupling)"},{"comment":"The claim that combining structural and functional parameters 'significantly improves' classification is not supported by any statistical test reported in the abstract. The AUC difference of 0.05 (0.87 vs 0.82) may or may not be significant; reporting confidence intervals for the AUC of each model and a paired test for the difference (e.g., DeLong test) is necessary. The current abstract only reports point estimates from 2000 Monte Carlo iterations, which do not by themselves establish significance.","section":"Results/Abstract (statistical significance)"},{"comment":"All structural features depend on AI segmentation of OCT volumes. The manuscript should report the segmentation algorithm, its training data, and validation accuracy, because errors or biases in segmentation would corrupt all structural parameters and affect the combined model's advantage over functional-only data. If a pre-existing, validated tool was used, this should be stated explicitly.","section":"Methods (AI segmentation)"}],"minor_comments":[{"comment":"The abstract would benefit from reporting sensitivity and specificity at a clinically relevant operating point, not only AUC, to help readers judge practical utility.","section":"Abstract (performance reporting)"},{"comment":"The list of six key predictors includes 'inferior RNFL and GCL+IPL thickness' in the sixth item, which overlaps with the second item 'inferior-temporal RNFL thickness'; please clarify whether these are distinct features or duplicates.","section":"Results/SHAP"},{"comment":"The phrase 'significantly improves' appears in the conclusions, but no significance threshold or methodology is described anywhere in the abstract; if a statistical test was performed, name it explicitly.","section":"Conclusions (significance language)"},{"comment":"The abstract does not place the work in the context of existing PACG progression prediction models or prior combined structural-functional classifiers; citing relevant prior work would clarify the novelty.","section":"Introduction/Related Work"}],"recommendation":"major_revision","confidential_remarks":"The editors may wish to request the analysis code and de-identified data (or a detailed protocol) to verify patient-level splitting, as this is the most serious threat to the headline claim. The absence of patient-level validation and confidence intervals in the abstract makes the current evidence insufficient for publication in a high-standard journal, but the issues are fixable if the authors can provide a rigorous patient-stratified validation. Also, the novelty relative to existing glaucoma progression prediction literature is not clearly articulated in the abstract."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Dear colleague,\n\nRead the abstract only; no full text. The paper asks a clinically meaningful question: which PACG eyes will progress fast enough to warrant early aggressive treatment? Combining OCT structure with sector VF function is a reasonable approach, and the SHAP result pointing to inferior MRW and RNFL thickness as key predictors is concrete. The cohort of 451 eyes from 299 patients is decent for this kind of work. The reported AUC 0.87 for the combined RF model, vs 0.82 structural and 0.78 functional only, is plausible.\n\nNow the soft spots, in proportion. The biggest one is the evaluation. 451 eyes from 299 patients means many patients contributed both eyes. The abstract says '2000 Monte Carlo iterations' but doesn't say whether splits are by patient or by eye. If eye-level, fellow eyes can leak across train and test, inflating the AUC. That's a load-bearing gap. No confidence intervals on the AUCs, no test for the difference, no external validation. These are all fixable in the full text, but on abstract alone the headline isn't trustworthy. The segmentation issue is real but secondary; even perfect segmentation won't help if the split is wrong.\n\nA smaller issue: the label is a VFI slope, and the functional features are baseline VF sensitivities from the same VF series. The abstract says baseline VF within six months of OCT, so likely not directly the slope, but shared measurement noise across serial VFs could create a subtle coupling. I'd want the full text to show that baseline sensitivity and the follow-up series used for the slope are handled cleanly.\n\nWho is this for: anyone modeling glaucoma progression or using OCT/VF fusion. The underlying design is standard and the question is relevant. A serious referee could quickly check the cross-validation and CI issues; if the full text does patient-level splits and gives honest intervals, this is a solid subfield contribution. I would not desk-reject. Send it to review, with a request to verify the split scheme and feature-label independence.","headline":"Clinically relevant PACG progression paper with a plausible 0.87 AUC, but the abstract lacks patient-level split details, so the headline result needs verification from the full text.","tokens_in":1646,"tokens_out":3079,"would_cite":false,"duration_ms":32237,"reading_group":"maybe","serious_thinker":"unclear","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"In PACG, combining optic-nerve structure with visual-field data predicts fast progressors better than either alone.","keywords":["primary angle closure glaucoma","glaucoma progression","optic nerve head","visual field","machine learning","Random Forest","SHAP","OCT"],"falsifier":"Take the same cohort and re-run the combined model with the 31 ONH parameters replaced by manual expert segmentation of the same OCT volumes; if the AUC drops to the functional-only level (0.78) or the structure-only level (0.82), the reported advantage of fusion depends on the AI segmentation rather than on the biological signal. A second check is to apply the trained model to an external PACG cohort scanned with a different OCT device and visual-field perimeter; if the AUC falls substantially, the result is overfit to this dataset.","tokens_in":714,"feed_emoji":"👁","tokens_out":4574,"duration_ms":40811,"temperature":0.7,"pith_summary":"This paper asks whether combining structural measurements of the optic nerve head with functional visual-field data can tell, early on, which eyes with primary angle closure glaucoma (PACG) will progress quickly. Using 451 eyes from 299 patients, it trains machine-learning classifiers on 31 AI-segmented optic nerve head parameters plus region-wise visual-field sensitivities. The best model, a Random Forest, reaches AUC 0.87 for separating fast from slow progressors, outperforming models that use only structural (0.82) or only functional (0.78) data. The authors conclude that the two data types carry complementary information, and that inferior optic nerve head morphology, especially minimum rim width and retinal nerve fibre layer thickness, is the strongest structural signal. If the result holds, clinics could flag fast-progressing PACG eyes earlier using routine OCT and visual-field tests.","feed_headline":"Combined structure and field data best predicts glaucoma progression","feed_subtitle":"In 451 eyes, the combined model hit AUC 0.87, beating structure-only 0.82 and field-only 0.78.","key_machinery":"The argument is carried by a fused feature set: 31 ONH parameters extracted from OCT volumes by AI segmentation, combined with mean sensitivity in five Glaucoma Hemifield Test regions per hemifield, aligned to RNFL distribution. These features are fed into several machine-learning classifiers, with the Random Forest performing best. Model predictions are benchmarked against a clinical definition of fast versus slow progression based on VFI slope, and SHAP is used to identify which features drive the classification. The working mechanism is complementarity: structural features capture tissue loss at the optic nerve head while functional features capture visual sensitivity loss, and their combination narrows the gap between anatomical damage and clinically observed field loss.","core_discovery":"The central claim is that fusing optic nerve head (ONH) structural features with sector-based visual field (VF) functional features materially improves classification of progression risk in PACG, compared with either modality alone. Fast progression is defined as visual field index (VFI) decline steeper than -2.0% per year; slow progression as -2.0% or flatter. Among 451 eyes, 82 were fast progressors. A Random Forest trained on both feature sets separated fast from slow eyes with AUC 0.87 over 2000 Monte Carlo iterations, versus 0.82 for structure-only and 0.78 for function-only models. SHAP attribution identifies six key predictors: inferior minimum rim width, inferior and inferior-temporal RNFL thickness, nasal-temporal lamina cribrosa curvature, superior nasal VF sensitivity, and a combined inferior RNFL plus ganglion cell-inner plexiform layer thickness measure. The paper reads this as evidence that inferior ONH morphology is a leading, partly independent marker of progression risk in PACG.","pith_inferences":["The definition of fast progression as VFI decline below -2.0% per year is a threshold; the model's advantage might shift if progression were defined by event-based criteria or structural rates, and testing that would clarify how stable the AUC gap is.","Because inferior ONH features dominate, one testable extension is whether the model can predict progression even earlier using only the first two years of data, which the current design (baseline VF within six months of OCT and more than five years of follow-up) does not directly address.","With 82 fast progressors out of 451 eyes, class imbalance is present; precision-recall curves would be a useful addition before clinical deployment, since AUC can look optimistic on imbalanced data.","If AI segmentation is the weakest link, external validation with manually segmented OCT volumes would directly test whether the combined model's edge survives segmentation noise."],"forward_implications":["Combined structural-functional models could be used to flag PACG eyes at high risk of rapid progression, prompting more frequent monitoring or earlier intervention.","The finding that inferior ONH features dominate suggests future imaging protocols and progression metrics should weight inferior minimum rim width and RNFL thickness.","The method is applicable to routine clinical data, OCT volumes and standard visual-field tests, so it could be deployed without new equipment.","The AUC gap (0.87 vs 0.82 and 0.78) suggests that neither modality alone is sufficient; models that ignore functional data may miss a meaningful share of fast progressors.","SHAP's list of six predictors gives a compact, interpretable set for clinical decision support rather than a black-box score."],"supporting_citations":[],"fun_headline_variants":["Combining structure and field data improves glaucoma progression prediction","Fused structural and functional data better classify PACG progression","Optic nerve and visual field fusion improves glaucoma progression AUC","Inferior optic nerve morphology key in combined glaucoma progression model","Data fusion of ONH and VF outperforms single-modality PACG models"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The load-bearing premise is that the AI segmentation of OCT volumes correctly extracts the 31 optic-nerve-head parameters; if that segmentation is biased or noisy, every structural feature is corrupted and the combined model's advantage over functional-only data would not generalize.","fun_headline_variants_meta":{"raw":{"variants":["Combining structure and field data improves glaucoma progression prediction","Fused structural and functional data better classify PACG progression","Optic nerve and visual field fusion improves glaucoma progression AUC","Inferior optic nerve morphology key in combined glaucoma progression model","Data fusion of ONH and VF outperforms single-modality PACG models"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000713,"raw_usage":{"total_tokens":3287,"prompt_tokens":1108,"completion_tokens":2179,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":724,"completion_tokens_details":{"reasoning_tokens":2093}},"tokens_in":724,"tokens_out":2179,"duration_ms":18716,"temperature":1.0,"reasoning_tokens":2093,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-15T17:12:51.009560+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Take the same cohort and re-run the combined model with the 31 ONH parameters replaced by manual expert segmentation of the same OCT volumes; if the AUC drops to the functional-only level (0.78) or the structure-only level (0.82), the reported advantage of fusion depends on the AI segmentation rather than on the biological signal. A second check is to apply the trained model to an external PACG cohort scanned with a different OCT device and visual-field perimeter; if the AUC falls substantially, the result is overfit to this dataset.","supporting_citations":[],"review_version":1}